Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Arrigo FG Cicero1, Sibel Ertek21Internal Medicine, Aging and Kidney Diseases Department, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy; 2Ufuk University, Medical Faculty, Dr Ridvan Ege Hospital, Department of Endocrinology and Metabolic Diseases, Ankara, TurkeyAb...
Main Authors: | Arrigo FG Cicero, Sibel Ertek |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-09-01
|
Series: | Nutrition and Dietary Supplements |
Online Access: | http://www.dovepress.com/berberine-metabolic-and-cardiovascular-effects-in-preclinical-and-clin-a3544 |
Similar Items
-
Factors Related with Non-Alcoholic Fatty Liver Disease in Normolipidemic Patients with 1-Hour Hyperglycemia
by: Sibel Ertek, et al.
Published: (2012-12-01) -
Potential Benefits of Berberine in the Management of Perimenopausal Syndrome
by: Cristiana Caliceti, et al.
Published: (2015-01-01) -
Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial
by: Jie V. Zhao, et al.
Published: (2021-07-01) -
Blood Pressure and Metabolic Effect of a Combination of Lercanidipine with Different Antihypertensive Drugs in Clinical Practice
by: Arrigo F.G. Cicero, et al.
Published: (2012-02-01) -
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study
by: Claudio Borghi, et al.
Published: (2008-06-01)